The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. METHODS: We assembled recent (i.e., 2002-2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. RESULTS: Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was $15.6 (range, $11.0-$20.6) billion. Total costs were as follows: chlamydia ($516.7 [$258.3-$775.0] million), gonorrhea ($162.1 [$81.1-$243.2] million), hepatitis B virus ($50.7 [$41.3-$55.6] million), HIV ($12.6 [$9.5-$15.7] billion), human papillomavirus ($1.7 [$0.8-$2.9] billion), herpes simplex virus type 2 ($540.7 [$270.3-$811.0] million), syphilis ($39.3 [$19.6-$58.9] million), and trichomoniasis ($24.0 [$12.0-$36.0] million). Costs associated with HIV infection accounted for more than 81% of the total cost. Among the nonviral STIs, chlamydia was the most costly infection. CONCLUSIONS: Sexually transmitted infections continue to impose a substantial cost burden on the payers of medical care in the United States. The burden of STIs would be even greater in the absence of STI prevention and control efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For females, the cost per STI case ranges from $247 for Human Papilloma Virus (HPV) to $804 for Herpes-Simples Virus (HSV2).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“The average cost per case of syphilis is $918 (either gender).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“For males, the cost per case ranges from $39 for Chlamydia to $985 for HSV2.”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
Citations
Cites
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893 · cited 1×
“However, this estimate is applicable when considering the best-case scenario of HIV care in the United States, implying that applying their estimate could overestimate the total direct cost of HIV, because not all patients with HIV receive care and not all those who receive care get the best care available.(25,26) Hut…”
BackgroundSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Estimated HIV Incidence in the United States, 2006–2009
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, J., Lansky, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017502 · Cited by 1,071 · cited 1×
“For instance, in the past few years, the reported annual incidence of chlamydia, syphilis, and genital warts has increased,(6) although the annual incidence of gonorrhea and HIV infection has been relatively stable.(6,7) In addition, given the rapid changes in health care technology and service delivery, the lifetime…”
BackgroundRisk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“5% of treated asymptomatic cases in women, with no PID assumed to develop in treated women with symptomatic chlamydia.(15) We assumed epididymitis developed in 1.”
BackgroundThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444 · cited 8×
“Screening costs for asymptomatic persons were not included; in our previous estimate, these costs were included as part of the overall burden of chlamydia for persons infected with chlamydia.(1) We used previously published estimates of diagnosis and treatment costs for patients diagnosed in private physician/ health…”
BackgroundMethodResultInfluentialSelf-citationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., Weinstein, M. C., Seage, G. R., Moore, R. D., & Freedberg, K. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000228021.89490.2a · Cited by 410 · cited 5×
“We reviewed 2 recent studies that estimated the direct lifetime cost of HIV infection in the United States (Schackman et al.(23) and Hutchinson et al.”
BackgroundMethodInfluentialHs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323 · cited 1×
“For example, the potential costs of liver transplantation were included in the 3 source studies cited earlier, whereas liver transplantation costs were not reflected in our original estimate.(1,22)”
Background
Cited by
Items 101–200 of 463
Wong, W. C. W., Zhao, Y., Wong, N. S., Parish, W. L., Miu, H. Y. H., Yang, L.-G., Emch, M., Ho, K., Fong, F., & Tucker, J. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172561 · Cited by 33
Chesson, H. W., Kirkcaldy, R. D., Gift, T. L., Owusu‐Edusei, K., & Weinstock, H. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000725 · Cited by 37
Self-citationUnderstanding of risk factors for the human papillomavirus (HPV) infection based on gender and race
Osazuwa‐Peters, N., Boakye, E. A., Rohde, R. L., Ganesh, R. N., Moiyadi, A. S., Hussaini, A. S., & Varvares, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-018-36638-z · Cited by 34
Ditkowsky, J., Shah, K. H., Hammerschlag, M. R., Kohlhoff, S. A., & Smith-Norowitz, T. A. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2248-5 · Cited by 34
Spielberg, F., Levy, V., Lensing, S., Chattopadhyay, I., Venkatasubramanian, L., Acevedo, N., Wolff, P., Callabresi, D., Philip, S., Lopez, T. P., et al. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302302 · Cited by 32
“Emergency room or urgent care 4 (2) 2 (3) 2 (1) .”
BackgroundThird-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis
Albright, C. M., Emerson, J. B., Werner, E. F., & Hughes, B. L. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000997 · Cited by 31
Neisseria gonorrhoeae — Rising Infection Rates, Dwindling Treatment Options
Blank, S., & Daskalakis, D. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1812269 · Cited by 31
Perceived stress and incident sexually transmitted infections in a prospective cohort
Turpin, R., Brotman, R. M., Miller, R. S., Klebanoff, M. A., He, X., & Slopen, N. B. (2019) · Annals of Epidemiology · doi:10.1016/j.annepidem.2019.01.010 · Cited by 39
Re-Thinking the Role of the Family in Medical Decision-Making
Cherry, M. J. (2015) · The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · doi:10.1093/jmp/jhv011 · Cited by 34
Sexually Transmitted Diseases Among Pregnant Women: 5 States, United States, 2009–2011
Williams, C. L., Harrison, L., Llata, E., Smith, R. A., & Meites, E. (2018) · Maternal and Child Health Journal · doi:10.1007/s10995-017-2422-9 · Cited by 32
“Although this estimate represents a considerable economic burden, it is a conservative one that does not include the costs associated with managing the adverse pregnancy outcomes associated with these infections (Owusu-Edusei et al. 2013).”
InfluentialLandovitz, R. J., Gildner, J. L., & Leibowitz, A. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000695 · Cited by 31
Lawyer, S. R., & Mahoney, C. T. (2017) · The Journal of Sex Research · doi:10.1080/00224499.2017.1350627 · Cited by 31
“6 billion (Owusu-Edusei et al., 2013) in the United States in 2008.”
BackgroundInfluentialCorrelates of STI Testing Among US Young Adults: Opportunities for Prevention
Thompson, E. L., Griner, S. B., Galvin, A. M., Lowery, A. D., & Lewis, M. A. (2020) · Prevention Science · doi:10.1007/s11121-020-01179-3 · Cited by 31
Surveillance systems for sexually transmitted infections: a global review
Mohammed, H. P., Hughes, G., & Fenton, K. A. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000235 · Cited by 30
Substance use and STI acquisition: Secondary analysis from the AWARE study
Feaster, D. J., Parish, C. L., Gooden, L. K., Matheson, T., Castellón, P. C., Duan, R., Pan, Y., Haynes, L. F., Schackman, B. R., Malotte, C. K., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.027 · Cited by 32
“INTRODUCTION Despite efforts to promote sexual risk reduction (Centers for Disease Control and Prevention (CDC), 2014; Owusu-Edusei et al., 2013; Satterwhite et al., 2013), sexually transmitted infections (STIs) still remain a significant financial and public health burden in the United States…”
BackgroundUnderstanding sexual healthcare seeking behaviour: why a broader research perspective is needed
Mapp, F., Wellings, K., Hickson, F., & Mercer, C. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2420-z · Cited by 28
Vieira‐Baptista, P., Silva, A., Costa, M., Aguiar, T., Saldanha, C., & Sousa, C. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16661 · Cited by 31
Llata, E., Cuffe, K. M., Picchetti, V., Braxton, J., & Torrone, E. (2021) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss7007a1 · Cited by 30
“9 billion in lifetime direct medical costs in the United States in 2018 (2).”
BackgroundA Community-Based Randomized Trial of Hepatitis B Screening Among High-Risk Vietnamese Americans
Grace, X., Fang, C. Y., Seals, B. F., Feng, Z., Tan, Y., Siu, P. T., Yeh, M. C., Golub, S. A., Nguyen, M. T., Tran, T. T., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303600 · Cited by 29
Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men
Mckenney, J. L., Chen, A., Hoover, K. W., Kelly, J., Dowdy, D. W., Sharifi, P., Sullivan, P. S., & Rosenberg, E. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178170 · Cited by 33
“4 [40] Costs, 2015 US$ Annual cost of PrEP 10,711 4,772–15,000 [16] Lifetime cost per HIV patient, discounted 327,503 150,000–500,000 [16], [29], [30] Average cost per case of STI treated (men) 180 99–295 [38], [41], [42] Average cost per STI test 67 27–80 [16] QALYs QALY gained per case of HIV averted, discounted 2.”
BackgroundFava, J. P., Colleran, J., Bignasci, F., Cha, R., & Kilgore, P. E. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1325980 · Cited by 29
“Recent data estimates the total lifetime direct medical cost of HPV infection in the United States at $1.7 [$0.8–2.9] billion, a cost second highest only to HIV among STIs.69 Several studies demonstrate substantial cost-effectiveness and savings through application of vaccination and screening programs that used mixed…”
BackgroundInfluentialThe condom purchase task: A hypothetical demand method for evaluating sexual health decision‐making
Strickland, J. C., Marks, K. R., & Bolin, B. L. (2020) · Journal of the Experimental Analysis of Behavior · doi:10.1002/jeab.585 · Cited by 31
Berry, M. S., Johnson, P. S., Collado, A., Loya, J. M., Yi, R., & Johnson, M. W. (2018) · Archives of Sexual Behavior · doi:10.1007/s10508-018-1155-1 · Cited by 28
“…spends roughly 16 billion dollars annually on diagnosis and treatment of sexually transmitted infections (STIs; Centers for Disease Control and Prevention [CDC], 2013; Owusu-Edusei et al., 2013), and HIV infection alone accounts for more than 80% of this total cost (Owusu-Edusei et al., 2013).”
Jackson, S. E., Yang, L., Veronese, N., Koyanagi, A., Sánchez, G. F. L., Grabovac, I., Soysal, P., & Smith, L. (2019) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2018-200230 · Cited by 32
Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea
Haese, E. C., Thai, V. C., & Kahler, C. M. (2021) · Vaccines · doi:10.3390/vaccines9070804 · Cited by 33
Alcohol Use Predicts Number of Sexual Partners for Female but not Male STI Clinic Patients
Carey, K. B., Senn, T. E., Walsh, J. L., Scott‐Sheldon, L. A. J., & Carey, M. P. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1177-9 · Cited by 30
“Nearly 20 million new cases of sexually transmitted infections (STI) occur each year, incurring direct medical costs of $16 billion [1].”
Sexually Transmitted Infections: Compelling Case for an Improved Screening Strategy
Hull, S., Kelley, S., & Clarke, J. L. (2017) · Population Health Management · doi:10.1089/pop.2017.0132 · Cited by 32
Ayoub, H. H., Chemaitelly, H. S., & Abu-Raddad, L. J. (2020) · Vaccines · doi:10.3390/vaccines8030366 · Cited by 30
Lanjouw, E., Ouburg, S., de Vries, H., Stary, A., Radcliffe, K. W., & Unemo, M. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415618838 · Cited by 36
“7 million in 2008 in the USA, among the non-viral STIs the most costly infection.(32,33) The direct costs associated with C.”
BackgroundWermers, R., Ostroski, T. L., & Hagler, D. A. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000281 · Cited by 27
“Owusu-Edusei et al. (2013) estimated the overall incidence cost of HPV in a given year as $1.7 billion.”
BackgroundInfluentialChesson, H. W., Laprise, J., Brisson, M., Martin, D., Ekwueme, D. U., & Markowitz, L. E. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001379 · Cited by 27
Self-citationOwusu‐Edusei, K., Roby, T., Chesson, H. W., & Gift, T. L. (2013) · Sexual Health · doi:10.1071/sh13021 · Cited by 29
Self-citationCost Savings of Red Cell Salvage During Cesarean Delivery
Albright, C. M., Rouse, D. J., & Werner, E. F. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000465 · Cited by 28
Marotta, P. L. (2017) · Journal of Urban Health · doi:10.1007/s11524-017-0179-5 · Cited by 30
Pinto, C. N., Dorn, L. D., Chinchilli, V. M., & Du, P. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000697 · Cited by 27
Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
Chesson, H. W., Kirkcaldy, R. D., Gift, T. L., Owusu‐Edusei, K., & Weinstock, H. (2014) · Emerging infectious diseases · doi:10.3201/eid2004.131288 · Cited by 28
Self-citationBerus, S. M., Adamczyk-Popławska, M., Młynarczyk-Bonikowska, B., Witkowska, E., Szymborski, T. R., Waluk, J. W., & Kamińska, A. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113358 · Cited by 26
Pearson, W. S., Cramer, R. C., Tao, G., Leichliter, J. S., Gift, T. L., & Hoover, K. W. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303263 · Cited by 26
Self-citationIncrease in Urgent Care Center Visits for Sexually Transmitted Infections, United States, 2010–2014
Pearson, W. S., Tao, G., Kroeger, K. A., & Peterman, T. A. (2017) · Emerging infectious diseases · doi:10.3201/eid2302.161707 · Cited by 26
Self-citationMontgomery, M. C., Raifman, J., Nunn, A. S., Bertrand, T. E., Uvin, A. Z., Marak, T. P., Comella, J., Almonte, A. A., & Chan, P. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000585 · Cited by 26
Garnett, G. P. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.007 · Cited by 28
Vaccines against Genital Herpes: Where Are We?
Kim, H. C., & Lee, H. K. (2020) · Vaccines · doi:10.3390/vaccines8030420 · Cited by 25
King, K. A., Vidourek, R. A., & Singh, A. (2014) · Sexuality & Culture · doi:10.1007/s12119-013-9214-1 · Cited by 25
Gaydos, C. A., Jett‐Goheen, M., Barnes, M., Dize, L., Barnes, P., & Hsieh, Y. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052058 · Cited by 25
Footman, A. P., Dagama, D., Smith, C. H., & Pol, B. J. V. D. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001461 · Cited by 25
Dize, L., West, S. K., Mkocha, H. A., Quinn, T. C., & Gaydos, C. A. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.11.010 · Cited by 24
“Sexually transmitted infections including CT and NG cost the US health care system about 19 billion dollars annually (Owusu-Edusei et al., 2013).”
BackgroundGuerrero-Beltrán, C., Diez, R. C., Sepúlveda‐Crespo, D., de la Mata, J., Gómez, R., Leal, M., Muñoz‐Fernández, M. Á., & Jiménez, J. L. (2017) · Nanoscale · doi:10.1039/c7nr05859d · Cited by 24
Pearson, W. S., Kreisel, K. M., Peterman, T. A., Zlotorzynska, M., Dittus, P., Habel, M. A., & Papp, J. R. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.08.007 · Cited by 24
Batteiger, T. A., Dixon, B. E., Wang, J., Zhang, Z., Tao, G., Tong, Y., Tu, W., Hoover, S., & Arno, J. N. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000928 · Cited by 24
Self-citationSerrano, J., Crouch, J. M., Albertson, K. M., & Ahrens, K. R. (2018) · Children and Youth Services Review · doi:10.1016/j.childyouth.2018.03.020 · Cited by 24
“Medical care costs associated with STIs were roughly $16 billion (Owusu-Edusei et al., 2013).”
BackgroundAdolescent Sexual Behavior and Emergency Department Use
Weisman, J. K., Chase, A., Badolato, G. M., Teach, S. J., Trent, M., Chamberlain, J. M., & Goyal, M. K. (2018) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001456 · Cited by 23
The Estimated Lifetime Medical Cost of Syphilis in the United States
Chesson, H. W., & Peterman, T. A. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001353 · Cited by 24
Self-citationUpdate on Treatment Options for Gonococcal Infections
Lancaster, J. W., Mahoney, M. V. G., Mandal, S., & Lawrence, K. R. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1627 · Cited by 24
Ireland, M. E., Chen, Q., Schwartz, H. A., Ungar, L., & Albarracín, D. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1252-2 · Cited by 25
Rectal chlamydia – should screening be recommended in women?
Andersson, N., Boman, J., & Nylander, E. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416653510 · Cited by 23
Robial, R., Longatto‐Filho, A., Roteli-Martins, C. M., da Silveira, M. F., Stauffert, D., Ribeiro, G., Linhares, I. M., Tacla, M., Zonta, M. A., & Baracat, E. C. (2017) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0111-8 · Cited by 25
Huang, S., Hung, J., Hu, L., Huang, M., Lee, S.-C., & Shen, C. (2018) · Medicine · doi:10.1097/md.0000000000012539 · Cited by 26
Cristillo, A. D., Bristow, C., Torrone, E., Dillon, J. R., Kirkcaldy, R. D., Dong, H. V., Grad, Y. H., Nicholas, R. A., Rice, P. A., Lawrence, K. R., et al. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000929 · Cited by 24
Kortsmit, K., Williams, L., Pazol, K., Smith, R. A., Whiteman, M. K., Barfield, W. D., Koumans, E. H. A., Kourtis, A. P., Harrison, L., Bauman, B. L., et al. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.1136 · Cited by 28
A Review of Sexually Transmitted Infections in Australia – Considerations in 2018
Thng, C. (2018) · Academic Forensic Pathology · doi:10.1177/1925362118821492 · Cited by 22
Duncan, S. A., Sahu, R., Dixit, S., Singh, S. R., & Dennis, V. A. (2020) · Mediators of Inflammation · doi:10.1155/2020/7461742 · Cited by 27
Eckman, M. H., Reed, J. L., Trent, M., & Goyal, M. K. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.3571 · Cited by 22
Translational gene expression control in Chlamydia trachomatis
Grieshaber, N. A., Chiarelli, T. J., Appa, C., Neiswanger, G., Peretti, K., & Grieshaber, S. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0257259 · Cited by 24
Bergen, G., Peterson, C., Ederer, D. J., Florence, C., Haileyesus, T., Kresnow, M., & Xu, L. (2014) · PubMed Central · Cited by 28
Chanakira, E., Goyder, E., Freeman, J. E., O’Cathain, A., Kinghorn, G. R., & Jakubovic, M. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414538950 · Cited by 26
Kumar, S., Chesson, H. W., & Gift, T. L. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001240 · Cited by 22
“4,22 Despite limitations of this analysis, our study presents an updated estimate of treatment and productivity costs per episode of chlamydia and gonorrhea under current STD treatment guidelines.”
MethodSelf-citationPol, B. J. V. D., Torres-Chavolla, E., Kodsi, S., Cooper, C. K., Davis, T. E., Fife, K. H., Taylor, S. N., Augenbraun, M. H., & Gaydos, C. A. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001280 · Cited by 24
Prabhu, V. S., Bansal, N., Liu, Z., Finalle, R., Sénécal, M., Kothari, S., Trowers, K., & Myers, E. R. (2021) · BMC Public Health · doi:10.1186/s12889-021-11664-1 · Cited by 22
Brawner, B. M., & Sutton, M. Y. (2017) · Ethics & Behavior · doi:10.1080/10508422.2017.1365303 · Cited by 22
“5 million, with HIV accounting for more than 80% of the total cost burden (Chesson et al., 2004; Owosu-Edusei et al., 2013).”
BackgroundInfluentialSocially Connected Neighborhoods and the Spread of Sexually Transmitted Infections
Newmyer, L., Evans, M., & Graif, C. (2022) · Demography · doi:10.1215/00703370-10054898 · Cited by 21
Recent advances in understanding and managing Chlamydia trachomatis infections
Marrazzo, J. M., & Suchland, R. J. (2014) · F1000Prime Reports · doi:10.12703/p6-120 · Cited by 25
Computational sensing of herpes simplex virus using a cost-effective on-chip microscope
Ray, A., Daloglu, M. U., Ho, J., Torres, A., McLeod, E. J., & Özcan, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05124-3 · Cited by 21
Datta, S., Mercer, C. H., & Keeling, M. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206501 · Cited by 21
Chang, S.-X., Chen, K.-K., Liu, X., Xia, N., Xiong, P., & Cai, Y.-M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234261 · Cited by 21
“7 million, respectively.[4] However, due to differences in the distribution of risk factors, the prevalence and burden of STIs vary widely around the world.”
BackgroundRukh, S., Khurana, R., Mickey, T., Anderson, L., Velasquez, C., & Taylor, M. M. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000070 · Cited by 21
“Sexually transmitted diseases impose a significant cost burden on the medical system in the United States.(14) Staff cost savings associated with the use of ET versus PV in this study was $2936 per 1000 clients, with only 20% of the clients being routed through ET.”
BackgroundBurlamaqui, J. C. F., Cassanti, A. C., Borim, G. B., Damrose, E. J., Villa, L. L., & da Silva, L. C. (2016) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2016.02.006 · Cited by 30
Sexual Behaviors and Sexually Transmitted Infections Among Male Veterans and Nonveterans
Evans, M. W., Borrero, S. B., Yabes, J. G., & Rosenfeld, E. A. (2017) · American Journal of Men s Health · doi:10.1177/1557988317698615 · Cited by 23
Dynamics of Drug Resistance: Optimal Control of an Infectious Disease
Chehrazi, N., Cipriano, L. E., & Enns, E. A. (2019) · Operations Research · doi:10.1287/opre.2018.1817 · Cited by 20
Anti-Virulence Therapeutic Approaches for Neisseria gonorrhoeae
Lim, K. Y. L., Mullally, C. A., Haese, E. C., Kibble, E. A., McCluskey, N. R., Mikucki, E. C., Thai, V. C., Stubbs, K. A., Sarkar‐Tyson, M., & Kahler, C. M. (2021) · Antibiotics · doi:10.3390/antibiotics10020103 · Cited by 24
EVO100 prevents chlamydia and gonorrhea in women at high risk of infection
Chappell, B. T., Mena, L. A., Maximos, B., Mollan, S. G., Culwell, K. R., & Howard, B. K. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.005 · Cited by 20
Lee, A. L. Z., Ng, V. W. L., Poon, G. L., Ke, X., Hedrick, J. L., & Yang, Y. Y. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400340 · Cited by 19
Chlamydia trachomatis Infection: Screening and Management.
Keegan, M. B., Diedrich, J. T., & Peipert, J. F. (2014) · PubMed · Cited by 19
Condoms and Contexts: Profiles of Sexual Risk and Safety Among Young Heterosexually Active Men
Masters, N. T., Casey, E. A., Beadnell, B. A., Morrison, D. M., Hoppe, M. J., & Wells, E. A. (2014) · The Journal of Sex Research · doi:10.1080/00224499.2014.953023 · Cited by 18
“health care system have been estimated at $16 billion per year (Owusu-Edusei et al., 2013).”
BackgroundNunes, A., Gomes, J. P., Karunakaran, K. P., & Brunham, R. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131695 · Cited by 18
Shale gas activity and increased rates of sexually transmitted infections in Ohio, 2000–2016
Deziel, N. C., Humeau, Z., Elliott, E. G., Warren, J. L., & Niccolai, L. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194203 · Cited by 17
Advances in vaccine development for Chlamydia trachomatis
Poston, T. B. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae017 · Cited by 23
“In the United States, > 1.8 million people are infected annually (Geisler et al. 2022 ) and direct treatment costs exceed $500 M (Owusu-Edusei et al. 2013 ).”
BackgroundInfluentialLai, J. C., Kahn, J. G., Tavakol, M., Peters, M. G., & Roberts, J. P. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12429 · Cited by 17
Maryland Alcohol Sales Tax and Sexually Transmitted Infections
Staras, S. A. S., Livingston, M. D., & Wagenaar, A. C. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.09.025 · Cited by 17
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000–2013)
Torre, G. L., Mannocci, A., Saulle, R., Colamesta, V., Meggiolaro, A., Mipatrini, D., & Sinopoli, A. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1166328 · Cited by 17
Medicaid Coverage of Sexually Transmitted Disease Service Visits
Pearson, W. S., Spicknall, I. H., Cramer, R. C., & Jenkins, W. D. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.02.019 · Cited by 17
Weng, R., Fu, H., Zhang, C. L., Ye, J. B., Hong, F., Chen, X. S., & Cai, Y. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000680 · Cited by 17
“7 million in the United States, which is a great burden to individuals and society [8].”
BackgroundZhang, Z., Zong, X., Bai, H., Fan, L., Li, T., & Liu, Z. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-022-07975-2 · Cited by 17
Senn, T. E., Walsh, J. L., & Carey, M. P. (2016) · Archives of Sexual Behavior · doi:10.1007/s10508-016-0714-6 · Cited by 19
“There are an estimated 20 million new STIs in the U.S. each year; rates of chlamydia and syphilis have increased over the past decade, whereas rates of gonorrhea have been relatively stable over this timeframe (Centers for Disease Control and Prevention, 2015; Owusu-Edusei et al., 2013).”
BackgroundRacial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013
Patel, C. G., Chesson, H. W., & Tao, G. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000405 · Cited by 17
“9 million cases occurring annually with direct medical costs of more than $500 million.(1,2) Approximately two-thirds of reported chlamydial infections occur among persons aged 15 to 24 years.”
BackgroundSelf-citationWray, T. B., Celio, M. A., Kahler, C. W., Barnett, N. P., Mastroleo, N. R., Operario, D., & Monti, P. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.04.011 · Cited by 17
Kottke, M., Whiteman, M. K., Kraft, J. M., Goedken, P., Wiener, J. B., Kourtis, A. P., & DiClemente, R. J. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.04.008 · Cited by 16
Sexually Transmitted Infection History among Adolescents Presenting to the Emergency Department
Bonar, E. E., Walton, M. A., Caldwell, M. T., Whiteside, L., Barry, K. L., & Cunningham, R. M. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2015.02.017 · Cited by 18
“Additionally, STIs result in approximately $16 billion in direct and indirect health-care expenses (9,10).”
Action Needed on Chlamydia Vaccines
Starnbach, M. N. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.05.006 · Cited by 16
The Impact of Public Health Spending on California STD Rates
Gallet, C. A. (2017) · International Advances in Economic Research · doi:10.1007/s11294-017-9631-2 · Cited by 16
The Effects of Condom Availability on College Women’s Sexual Discounting
Lemley, S. M., Jarmolowicz, D. P., Parkhurst, D., & Celio, M. A. (2017) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1040-3 · Cited by 18
Metadata
- Authors
- Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K.
- Corresponding author
- Chesson, Harrell W.
- Gift, Thomas L.
- Tao, Guoyu
- Kent, Charlotte K.
- Venue
- Sexually Transmitted Diseases
- Published
- 2013-03
- Volume
- 40
- Issue
- 3
- Pages
- 197-201
- ISSN
- 0148-5717 (ISSN-L)
- OpenAlex
- W2064915358
- Cited by
- 452
- References
- 32
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 20 · 2022: 21 · 2021: 37 · 2020: 39 · 2019: 39 · 2018: 45 · 2017: 75 · 2016: 41 · 2015: 46 · 2014: 53 · 2013: 17
- FWCI
- 47.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sexually Transmitted Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- sexually transmitted infections, direct medical costs, HIV, chlamydia, gonorrhea, hepatitis B virus, human papillomavirus, herpes simplex virus type 2, syphilis, trichomoniasis, cost burden
- MeSH terms
- Chlamydia Infections, Condylomata Acuminata, Female, Gonorrhea, Hepatitis B, Herpes Genitalis, Humans, Male, Sexually Transmitted Diseases, Syphilis, Trichomonas Infections, United States, HIV Infections, Health Care Costs, Cost of Illness, Models, Economic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.